Literature DB >> 10381923

Changing pattern of chronic hepatitis D in Southern Europe.

F Rosina1, P Conoscitore, R Cuppone, G Rocca, A Giuliani, R Cozzolongo, G Niro, A Smedile, G Saracco, A Andriulli, O G Manghisi, M Rizzetto.   

Abstract

BACKGROUND & AIMS: The aim of this study was to assess changes in the clinical pattern of hepatitis D virus (HDV) infection in Italy, brought about by improved control of hepatitis B and D viruses, and to establish the natural history of chronic hepatitis D.
METHODS: Histological diagnosis and clinical features of 122 patients with HDV recruited from 1987 to 1996 in three Italian tertiary referral centers (Torino, northern Italy; San Giovanni Rotondo and Castellana Grotte, southern Italy) were compared with those of 162 patients collected in the same centers in the previous decade. Patients from both groups with at least 6 months of follow-up were included in a new subgroup to assess the natural history of the disease.
RESULTS: Among 162 patients referred from 1977 to 1986, 9 (6%) had mild hepatitis at histology vs. 9 (8%) of 122 patients referred in the second decade; 105 (65%) vs. 21 (17%) had severe hepatitis; 46 (28%) vs. 38 (31%) had histological asymptomatic cirrhosis; and 2 (1%) vs. 54 (44%) had clinically overt cirrhosis. For 159 patients (121 men and 38 women; mean age, 34 +/- 11), a follow-up of more than 6 months was documented, and they were included in the natural history subgroup. After 78 +/- 59 months of follow-up, 112 (70%) survived free of liver transplantation: 9 underwent transplantation, 32 died of liver failure, and 6 of acquired immunodeficiency syndrome. Estimated 5- and 10-year probability of survival free of orthotopic liver transplantation was 100% and 100% for patients with mild hepatitis, 90% and 90% for severe hepatitis, 81% and 58% for histological asymptomatic cirrhosis, and 49% and 40% for clinical cirrhosis (P < 0.01), respectively.
CONCLUSIONS: Occurrence of fresh and severe forms of hepatitis D has diminished greatly in Italy. Contemporary patients represent cohorts infected years ago who survived the immediate medical impact of hepatitis D. The disease has been asymptomatic and nonprogressive in a minority; in the majority, it rapidly advanced to cirrhosis but thereafter subsided with stable clinical conditions for more than a decade.

Entities:  

Mesh:

Year:  1999        PMID: 10381923     DOI: 10.1016/s0016-5085(99)70563-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

1.  Current concept in the pathophysiology of hepatitis delta infection.

Authors:  Grazia Anna Niro; Antonina Smedile
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

2.  Alpha interferon and ribavirin combination therapy of chronic hepatitis D.

Authors:  Sabahattin Kaymakoglu; Cetin Karaca; Kadir Demir; Sule Poturoglu; Ahmet Danalioglu; Selim Badur; Murvet Bozaci; Fatih Besisik; Yilmaz Cakaloglu; Atilla Okten
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 3.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy.

Authors:  M De Paschale; M T Manco; L Belvisi; C Magnani; T Re; P Viganò; S Biagiotti; F Capelli; A Mazzone; M P Baldacci; A Ferrara; A L Neri; C M Guastoni; R A Bonazzina; B Brando; P Clerici
Journal:  Infection       Date:  2012-02-25       Impact factor: 3.553

5.  Hepatitis delta infection in Italian patients: towards the end of the story?

Authors:  Tommaso Stroffolini; Evangelista Sagnelli; Caterina Sagnelli; Maurizio Russello; Massimo De Luca; Floriano Rosina; Bruno Cacopardo; Giuseppina Brancaccio; Caterina Furlan; Giovanni Battista Gaeta; Anna Licata; Piero Luigi Almasio
Journal:  Infection       Date:  2016-11-05       Impact factor: 3.553

Review 6.  Hepatitis D Virus: Introduction and Epidemiology.

Authors:  Mario Rizzetto
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

7.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

8.  Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Authors:  Kuo-Chin Chang; Pei-Shan Tsai; Mei-Chin Hsu; Shu-Fen Hung; Chin-Chen Tsai; Sheng-Nan Lu
Journal:  J Gastroenterol       Date:  2010-01-07       Impact factor: 7.527

9.  Clinical presentation and genotype of hepatitis delta in Karachi.

Authors:  Tariq Moatter; Zaigham Abbas; Sabhita Shabir; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

10.  Hepatitis d.

Authors:  Elif S Koytak; Cihan Yurdaydin; Jeffrey S Glenn
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.